Back to Treatments
Transplant & Hematology

Aplastic Anemia Treatment

再生障碍性贫血治疗

Duration

IST: 3-6 months to response; HSCT: 4-6 weeks inpatient

Recovery

IST: 3-6 months for blood count recovery; HSCT: 3-6 months for immune reconstitution

$

Savings

~84% vs US

Price Comparison
China$15,000 - $50,000
$32,500
United States$100,000 - $300,000
$200,000
Save approximately 84%

Average savings compared to US prices

About This Treatment

Comprehensive aplastic anemia management including immunosuppressive therapy (ATG + cyclosporine + eltrombopag), supportive care, and allogeneic stem cell transplantation for severe cases. China's hematology centers have extensive experience treating aplastic anemia with both IST and transplant approaches, with particular expertise in haploidentical HSCT for patients lacking matched donors, offering cure rates of 80-90% in young patients.

Procedure Steps
1

Diagnostic Confirmation & Severity Grading

Bone marrow biopsy with cellularity assessment, flow cytometry to exclude MDS/PNH, and genetic testing for inherited forms

Duration: 3-5 days
2

Treatment Strategy Decision

Age-based algorithm: HSCT preferred for young patients with matched donor; IST for older patients or those without donors

Duration: 1 week
3

Treatment Delivery

Horse ATG + cyclosporine + eltrombopag for IST pathway, or conditioning and allogeneic HSCT for transplant pathway

Duration: IST: 5-day ATG course; HSCT: 4-6 weeks
4

Response Monitoring & Supportive Care

Regular blood counts, transfusion support, infection management, and assessment for clonal evolution

Duration: 3-12 months
Benefits
  • High cure rates with HSCT in young patients (80-90%)
  • Haploidentical transplant option for patients without matched donors
  • Eltrombopag addition improves IST response rates to 80%+
  • Comprehensive supportive care and blood product availability
Considerations
  • ATG can cause severe allergic reactions and serum sickness
  • HSCT carries graft failure and GVHD risks
  • Clonal evolution to MDS or AML in 10-15% of IST patients
  • Prolonged immunosuppression increases infection vulnerability

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.